Activator protein 1 (AP-1, also known as JUN) transcription factors are dimers of JUN, FOS, MAF and activating transcription factor (ATF) family proteins characterized by basic region and leucine zipper domains 1 . Many AP-1 proteins contain defined transcriptional activation domains, but BATF and the closely related BATF3 (refs 2, 3) contain only a basic region and leucine zipper, and are considered to be inhibitors of AP-1 activity [3] [4] [5] [6] [7] [8] . Here we show that Batf is required for the differentiation of IL17-producing T helper (T H 17) cells 9 . T H 17 cells comprise a CD4 1 T-cell subset that coordinates inflammatory responses in host defence but is pathogenic in autoimmunity [10] [11] [12] [13] . Batf 2/2 mice have normal T H 1 and T H 2 differentiation, but show a defect in T H 17 differentiation, and are resistant to experimental autoimmune encephalomyelitis. Batf 2/2 T cells fail to induce known factors required for T H 17 differentiation, such as RORct 11 (encoded by Rorc) and the cytokine IL21 (refs [14] [15] [16] [17] . Neither the addition of IL21 nor the overexpression of RORct fully restores IL17 production in Batf 2/2 T cells. The Il17 promoter is BATF-responsive, and after T H 17 differentiation, BATF binds conserved intergenic elements in the Il17a-Il17f locus and to the Il17, Il21 and Il22 (ref. 18 ) promoters. These results demonstrate that the AP-1 protein BATF has a critical role in T H 17 differentiation.
In a gene expression survey ( Supplementary Fig. 1a ), we identified the basic leucine zipper transcription factor ATF-like 7 Batf to be highly expressed in T H 1, T H 2 and T H 17 cells compared to naive T and B cells. BATF and BATF3 (refs 2, 3) form heterodimers with JUN 6, 7 and are considered to be repressors of AP-1 activity 3, 5, 6, 8, 19 . To assess the role of BATF in T cell differentiation 20 , we generated Batf 2/2 mice ( Supplementary Fig. 2a, b ). Batf 2/2 mice lacked detectable BATF protein, were fertile and appeared healthy. BATF protein was low in naive T cells, increased in T H 2 cells, induced by activation ( Supplementary Fig. 2 ), present in the nucleus and cytoplasm, but showed increased nuclear translocation after activation ( Fig. 1a and Supplementary Fig. 1b , c). Batf 2/2 mice had normal thymus, spleen and lymph node development, and normal CD4 1 and CD8 1 T cell development ( Supplementary Figs 3, 4a , b). Although Batf-transgenic mice had altered natural killer T cell development 21 , Batf 2/2 mice had normal development of natural killer T cells ( Supplementary Fig. 4c ), B cells ( Supplementary Fig. 4d , e), and conventional and plasmacytoid dendritic cells ( Supplementary Fig. 5a , b).
Batf 2/2 T cells showed normal T H 1 and T H 2 differentiation ( Supplementary Fig. 6a ). Under T H 17 conditions, Batf 2/2 T cells, but not Batf 1/2 T cells, showed a marked reduction in IL17 production, but had normal levels of IL2, IFN-c and IL10 (Fig. 1b, c) .
Batf 2/2 DO11.10 1 T cells showed loss of IL17 even after several passages under T H 17 conditions ( Supplementary Fig. 6b ). Batf 2/2 CD8 1 T cells also failed to produce IL17 ( Supplementary Fig. 6c ). We generated transgenic mice expressing Flag-tagged Batf under the control of the Cd2 promoter 22 . Batf-transgenic DO11.10 1 CD4 1 T cells and CD8 1 T cells had increased IL17 production under T H 17 conditions compared to controls ( Supplementary Fig. 6d , e). Lamina propria CD4 1 T cells, which constitutively express IL17 in wild-type mice 11 , failed to produce IL17 in Batf 2/2 mice ( Supplementary  Fig. 6f ).
T H 17 cells are the major pathogenic population in experimental autoimmune encephalomyelitis 10 (EAE), although factors other than IL17A and IL17F can contribute to the disease 23 . Batf 1/1 mice immunized with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG(35-55); Fig. 2 ) developed EAE, but Batf 2/2 mice were completely resistant ( Fig. 2a ). At peak disease, central nervous system (CNS)-infiltrating and splenic CD4 1 T cells from Batf 1/1 mice produced abundant IL17 and IFN-c, whereas T cells from Batf 2/2 mice did not produce IL17 ( Fig. 2b and Supplementary Fig. 7a ). Because IL6-deficient mice are resistant to EAE owing to a compensatory increase in FOXP3 1 T regulatory (T reg ) cells 14 , we analysed splenic Batf 1/1 and Batf 2/2 CD4 1 T cells for FOXP3 expression before and after MOG(35-55) immunization ( Supplementary Fig. 7b , c). Batf 2/2 mice had lower basal numbers of splenic FOXP3 1 T cells compared to Batf 1/1 mice, but showed no change in FOXP3 1 expression after MOG(35-55) immunization ( Supplementary Fig.  7b , c), suggesting that their resistance to EAE is not due to an increase in T reg cells. To determine whether the resistance to EAE in Batf 2/2 mice resulted from a defect within T cells or other immune cells, we injected naive Batf 1/1 CD4 1 T cells or PBS control buffer into mice before MOG(35-55) immunization ( Fig. 2c ). Batf 2/2 mice receiving PBS remained resistant to EAE, but Batf 2/2 mice receiving naive Batf 1/1 CD4 1 T cells developed severe EAE ( Fig. 2c and Supplementary Table 1 ) with CNS-infiltrating IL17-producing CD4 1 T cells ( Supplementary Fig. 7d ). Thus, Batf 2/2 mice have a T-cell-intrinsic defect preventing EAE.
Batf could control T H 17 development by regulating IL6 or TGF-b signalling. IL6 receptor expression and IL6-induced STAT3 phosphorylation were normal in Batf 2/2 T cells ( Supplementary Fig. 8a , b). TGF-b induced normal levels of FOXP3 in Batf 2/2 CD4 1 T cells ( Supplementary Fig. 8d ). Whereas Batf 2/2 T cells failed to fully downregulate FOXP3 in response to IL6 (ref. 12 ), neutralization of IL2 abrogated increased FOXP3 in Batf 2/2 T cells, without restoring IL17 production ( Supplementary Fig. 8d, e ). Thus, Batf 2/2 T cells exhibit normal TGF-b signalling and proximal IL6 signalling, indicating Batf may regulate downstream target genes.
IL21, an early target of IL6 signalling in CD4 1 T cells 17 , is required for T H 17 development [14] [15] [16] . IL21 was reduced in Batf 2/2 CD4 1 T cells activated under T H 17 conditions (Fig. 3a ). The addition of IL21 failed to rescue T H 17 development in Batf 2/2 T cells ( Fig. 3b ), but IL21-induced STAT3 phosphorylation was intact ( Supplementary   Fig. 8c ), suggesting that Batf regulates other factors besides IL21 during T H 17 differentiation.
We performed DNA microarrays and quantitative PCR with reverse transcription (qRT-PCR) of Batf 1/1 and Batf 2/2 T cells activated with combinations of IL6 and/or TGF-b ( Fig. 3c, d and Supplementary Fig. 9 ). This analysis identified several genes known to regulate T H 17 development as Batf-dependent ( Fig. 3c, d , Supplementary Fig. 9c and Supplementary Table 2 ), including Rorc 17 , Rora 24 , the aryl hydrocarbon receptor (Ahr) 25, 26 , Il22 (ref. 18 ) and Il17. However, Irf4 (ref. 13 ) and suppressor of cytokine signalling (Socs1-7) gene expression were unchanged in Batf 2/2 T cells ( Supplementary Fig. 9b and Supplementary Table 4 ). Early induction of RORct was normal in Batf 2/2 T cells, but was not maintained 62 h after stimulation ( Supplementary Fig. 11a ). Batf seemed to be necessary for the expression of a subset of IL6-induced genes, but was not required for the expression of TGF-b-induced genes ( Fig. 3c, Supplementary Fig. 9a and Supplementary Tables 2   IFN- and 3). However, Batf did not globally affect IL6-induced responses, because IL6-induced liver acute phase responses appeared normal in Batf 2/2 mice ( Supplementary Fig. 10 ).
Because RORct acts directly on the Il17 promoter 27,28 , we addressed whether RORct could rescue T H 17 development in Batf 2/2 T cells. In Batf 1/1 T cells, retroviral RORct expression induced 38% IL17 production, compared to only 1.6% IL17 production induced by control retrovirus (Fig. 3e and Supplementary  Fig. 11c) 11, 13 . However, in Batf 2/2 T cells, retroviral RORct expression induced only 5.7% IL17 production ( Fig. 3e and Supplementary  Fig. 11c ). Even under T H 17-inducing conditions, retroviral RORct expression did not fully restore IL17 production in Batf 2/2 T cells ( Supplementary Fig. 11b, c) . Retroviral expression of both BATF and RORct in Batf 2/2 T cells induced 26% IL17 production, compared to only 5% with RORct alone and 14% with BATF alone ( Supplementary Fig. 11d ), suggesting that there is potential synergy between RORct and BATF, and a possible direct action of BATF in transcription of Il17 and other T H 17-specific genes.
We used a reverse-strand retroviral reporter 29 to examine Il17 promoter activity in primary Batf 1/1 and Batf 2/2 T cells (Fig. 4a ). Three days after activation, Batf 2/2 CD4 1 T cells showed considerably less reporter activity than Batf 1/1 T cells, suggesting that the proximal Il17 promoter is Batf-responsive (Fig. 4a ). Using chromatin immunoprecipitation (ChIP) analysis of several conserved regions within the Il17a-Il17f locus ( Supplementary Fig. 12a ), we found that BATF specifically bound to the 19.6 kilobase (kb) and 128 kb intergenic regions within 24 h after activation ( Fig. 4b and Supplementary  Fig. 12b, c) . By day 5 after stimulation, BATF bound specifically to several intergenic regions and to the proximal Il17a and Il17f promoters ( Fig. 4b and Supplementary Fig. 12b, c) , with distal elements showing more rapid and stronger binding than proximal elements. We next examined BATF binding to a consensus AP-1 probe 6 by electrophoretic mobility shift assays (EMSAs). This probe formed two complexes in Batf 1/1 T H 17 cell extracts (Fig. 4c ) that were dependent on stimulation ( Supplementary Fig. 13a ). Only the upper complex formed in Batf 2/2 T H 17 cells (Fig. 4c ). An anti-BATF antibody inhibited the lower complex. In CD2-N-Flag-Batf-transgenic T H 17 cell extracts, the lower complex was specifically supershifted by an anti-Flag antibody (Fig. 4c) . Thus, only the lower complex binding the consensus AP-1 probe in T H 17 cells contains BATF.
Several potential BATF-binding sites were identified by EMSAs in the Il17, Il21 and Il22 proximal promoters, including the Il17 promoter region (2188 to 2210) that bound BATF in ChIP ( Fig. 4b and Supplementary Fig. 13b-d) . Another BATF-binding Il17 promoter region (2155 to 2187) overlapped with a reported RORct-binding element 27 . As an EMSA probe, this region forms two complexes in T H 17 cells (Fig. 4d) , with the lower complex being selectively inhibited by an anti-BATF antibody, absent in Batf 2/2 T H 17 cells, and supershifted by an anti-Flag antibody in Batf-transgenic T H 17 extracts (Fig. 4d ). We confirmed BATF binding to the Il21 and Il22 promoters by ChIP analysis (Supplementary Fig. 13e ). The program CONSENSUS 30 determined that the BATF-binding element in the Il17, Il21 and Il22 promoters resembles canonical AP-1 elements at positions 1 to 3, with variation at the remaining nucleotides ( Supplementary Fig. 13f ). CONSENSUS did not identify other transcription-factor-binding sites enriched near BATF-binding elements. We determined the composition of the BATF-containing complex using supershift analysis (Fig. 4e) . The upper complex supershifted with a pan-anti-FOS antibody, whereas the lower complex supershifted with a pan-anti-JUN and anti-BATF antibodies. Anti-JUNB supershifted most of the lower complex, but antibodies against JUN (also known as c-JUN), JUND, ATF1 or ATF3 did not. Thus, BATF preferentially forms heterodimers with JUNB during T H 17 differentiation.
Although Batf and Batf3 were considered to be AP-1 inhibitors 3-8 , we have shown that they are required for the development of specific immune lineages 2 . Batf is selectively required for T H 17 development, but unlike Irf4 (ref. 13 ), it is not required for T H 2 development. Because Batf is also expressed in T H 1 and T H 2 cells, it probably cooperates with other T H 17-specific factors to regulate target genes. Future work will determine whether the actions of BATF involve distinct DNA binding specificity or unique protein-protein interactions with T H 17 specific factors.
METHODS SUMMARY
Mice. Batf 2/2 mice were generated by homologous recombination, deleting exons 1 and 2 of the Batf gene on the pure 129SvEv genetic background. The neomycin-resistance cassette was removed from the targeted Batf allele in embryonic stem cells before the generation of mice. T cell differentiation assays. Naive CD4 1 CD62L 1 CD25 2 T cells (also known as CD4 1 SELL 1 IL2RA 2 ) were isolated by cell sorting and activated with platebound anti-CD3 (also known as CD3E) and soluble anti-CD28 antibodies. Cultures were supplemented with anti-IL4 (11B11; hybridoma supernatant), IFN-c (Peprotech; 0.1 ng ml 21 ) and IL12 (Genetics Institute; 10 U ml 21 ) for T H 1; anti-IFN-c (H22; gift from R.D. Schreiber; 10 mg ml 21 ), anti-IL12 (Tosh; BioXcell; 10 mg ml 21 ) and IL4 (Peprotech; 10 ng ml 21 ) for T H 2; anti-IL4, anti-IL12, anti-IFN-c, IL6 (Peprotech; 20 ng ml 21 ) and TGF-b (Peprotech; 0.5 ng ml 21 ) for T H 17 differentiation. Unless otherwise indicated, 3 days after activation cells were restimulated with phorbol myristate acetate (PMA) and ionomycin for 4 h for intracellular cytokine analysis by flow cytometry. Intracellular staining. For intracellular cytokine staining, cells were stained for surface markers followed by fixation with 2% formaldehyde for 15 min at room temperature. Cells were then washed once in 0.05% saponin and stained with anti-cytokine antibodies in 0.5% saponin. Anti-phospho-STAT3 antibody (BD Pharmingen) was used according to the manufacturer's recommendations. In brief, cells were stained for surface markers followed by fixation with 90% methanol at 220 uC overnight. Cells were then washed and stained for phosphorylated-STAT3 in PBS containing 3% FCS. FOXP3 staining was performed according to the manufacturer's recommendations using FOXP3 staining buffers (eBioscience).
Induction of EAE. Mice (7-10 weeks old) were immunized subcutaneously with 100 mg MOG(35-55) peptide (Sigma) emulsified in complete Freund's adjuvant (incomplete Freund's adjuvant supplemented with 500 mg Mycobacterium tuberculosis). One and three days later, mice were given 300 ng Pertussis Toxin (List Biological Laboratories) intraperitoneally. Clinical scores were assessed as described in Methods. For T-cell transfer experiments, mice were injected with either PBS or 10 7 Batf 1/1 CD4 1 T cells 4 days before MOG(35-55) immunization 13 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
